GlucoSet
Trondhjem
About GlucoSet
GlucoSet is medical device company that is developing sensor technology for improved glucose control in intensive care units. Blood glucose levels are elevated and unstable in hospital intensive care unit (ICU) patients. This leads to costly infections, increased length of stay and mortality. The GlucoSet intravascular sensor delivers continuous and accurate information on patient's blood glucose level, enabling normalization of glucose levels, without the risk of sudden and dangerously low glucose levels.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $12.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2023)
- Website: glucoset.com
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/glucoset-94991 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.